Back to Skandinaviska Enskilda Banken AB (publ) Skandinaviska Enskilda Banken AB (publ)

KRYSKRYS
Showing 7 of 21 quarters

Position history for Skandinaviska Enskilda Banken AB (publ)Skandinaviska Enskilda Banken AB (publ)'s holdings in Krystal Biotech, Inc.

Skandinaviska Enskilda Banken AB (publ) previously held 0 shares of KRYS (Krystal Biotech, Inc.), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$23M

Total Shares Change

-126,082

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$263.80
0
2025-Q4
Decreased
46,732
-22.1%
$11.5M0.0%$247.88
0
2025-Q3
Unchanged
59,978
0.0%
$10.6M0.0%$176.75
0
2025-Q2
Unchanged
59,978
0.0%
$8.2M0.0%$138.88
0
2025-Q1
Decreased
59,978
-32.6%
$10.8M0.1%$183.92
0
2024-Q4
Decreased
89,047
-29.4%
$14.2M0.1%$159.80
0
2024-Q3
Decreased
126,082
-34.2%
$23M0.1%$177.14
0

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used